Showing results (1261-1270 of 1,326) with videos related to

Sort By:
Pageof 133
Advances in Therapy|March 23, 2024
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on VortioxetineAngela T H Kwan, Ziji Guo, Felicia Ceban, et al.
Current Medical Research and Opinion|June 11, 2024
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysisKayla M Teopiz, Angela T H Kwan, Gia Han Le, et al.
Brain : a Journal of Neurology|November 8, 2023
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trialRoger S McIntyre, Lee Phan, Angela T H Kwan, et al.
Npj Mental Health Research|March 25, 2026
Exploratory characterization of gut microbiota and cognitive profiles in adolescents with subthreshold depression: a shotgun metagenomics sequencing studyRunhua Wang, Rong Ma, Yuanyuan Cai, et al.
Obesity Research & Clinical Practice|October 29, 2015
Binge eating in adults with mood disorders: Results from the International Mood Disorders Collaborative ProjectHanna O Woldeyohannes, Joanna K Soczynska, Nadia A Maruschak, et al.
BMJ Open|June 25, 2017
The Bipolar Illness Onset study: research protocol for the BIO cohort studyLars Vedel Kessing, Klaus Munkholm, Maria Faurholt-Jepsen, et al.
CNS Spectrums|April 20, 2017
Guidelines for the recognition and management of mixed depressionStephen M Stahl, Debbi A Morrissette, Gianni Faedda, et al.
Bipolar Disorders|September 13, 2017
Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task ForceK W Miskowiak, K E Burdick, A Martinez-Aran, et al.
JAMA Psychiatry|April 15, 2026
Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic ReviewDiana K Orsini, Sabrina Wong, Sara Di Luch, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsSidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Pageof 133